Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor

• Christine L. Hammond,

  Roles Data curation, Formal analysis, Investigation, Methodology, Writing – original draft

  Affiliation Flaum Eye Institute, School of Medicine and Dentistry, University of Rochester, Rochester, New York, United States of America

  ⨯
• Elisa Roztocil,

  Roles Data curation, Investigation, Methodology

  Affiliation Flaum Eye Institute, School of Medicine and Dentistry, University of Rochester, Rochester, New York, United States of America

  ⨯
• Richard P. Phipps,

  Roles Conceptualization, Data curation, Investigation, Methodology

  Affiliation Department of Environmental Medicine, School of Medicine and Dentistry, University of Rochester, Rochester, New York, United States of America

  ⨯
• Steven E. Feldon,

  Roles Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Writing – review & editing

  Affiliation Flaum Eye Institute, School of Medicine and Dentistry, University of Rochester, Rochester, New York, United States of America

  ⨯
• Collynn F. Woeller

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: Collynn_Woeller@urmc.rochester.edu

  Affiliations Flaum Eye Institute, School of Medicine and Dentistry, University of Rochester, Rochester, New York, United States of America, Department of Environmental Medicine, School of Medicine and Dentistry, University of Rochester, Rochester, New York, United States of America

  http://orcid.org/0000-0001-7197-5057

  ⨯